As of 2026-01-02, the Relative Valuation of Dyne Therapeutics Inc (DYN) is (35.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.56 USD, the upside of Dyne Therapeutics Inc based on Relative Valuation is -283.9%.
The range of the Relative Valuation is (25.88) - (45.82) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 15.4x | 12.0x |
| Forward P/E multiples | 8.7x - 15.7x | 12.2x |
| Fair Price | (25.88) - (45.82) | (35.98) |
| Upside | -232.3% - -334.2% | -283.9% |
| Date | P/E |
| 2025-12-31 | -6.59 |
| 2025-12-30 | -6.47 |
| 2025-12-29 | -6.60 |
| 2025-12-26 | -6.75 |
| 2025-12-24 | -6.86 |
| 2025-12-23 | -6.88 |
| 2025-12-22 | -7.00 |
| 2025-12-19 | -6.69 |
| 2025-12-18 | -6.25 |
| 2025-12-17 | -6.37 |
| 2025-12-16 | -6.59 |
| 2025-12-15 | -6.60 |
| 2025-12-12 | -6.49 |
| 2025-12-11 | -6.54 |
| 2025-12-10 | -6.64 |
| 2025-12-09 | -6.21 |
| 2025-12-08 | -7.48 |
| 2025-12-05 | -6.83 |
| 2025-12-04 | -6.96 |
| 2025-12-03 | -6.77 |
| 2025-12-02 | -6.74 |
| 2025-12-01 | -6.95 |
| 2025-11-28 | -7.38 |
| 2025-11-26 | -7.13 |
| 2025-11-25 | -7.01 |
| 2025-11-24 | -7.30 |
| 2025-11-21 | -7.14 |
| 2025-11-20 | -6.78 |
| 2025-11-19 | -6.94 |
| 2025-11-18 | -7.06 |
| 2025-11-17 | -6.82 |
| 2025-11-14 | -6.33 |
| 2025-11-13 | -6.35 |
| 2025-11-12 | -6.27 |
| 2025-11-11 | -6.63 |
| 2025-11-10 | -6.24 |
| 2025-11-07 | -6.19 |
| 2025-11-06 | -6.14 |
| 2025-11-05 | -7.04 |
| 2025-11-04 | -7.25 |
| 2025-11-03 | -8.13 |
| 2025-10-31 | -7.61 |
| 2025-10-30 | -7.94 |
| 2025-10-29 | -7.96 |
| 2025-10-28 | -8.19 |
| 2025-10-27 | -8.15 |
| 2025-10-24 | -5.77 |
| 2025-10-23 | -5.56 |
| 2025-10-22 | -5.51 |
| 2025-10-21 | -5.64 |